Revenue trajectory remains highly unstable with a 146.3% contraction in 2025Q4, while reported gross margins reached an anomalous 93.9% that warrants further investigation into potential non-recurring accounting adjustments.
Accendra Health, Inc. (ACH) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Sales/Revenue | 2.55B | 2.76B | 10.7B | 10.33B | 9.96B | 9.79B | 8.48B | 9.21B | 9.42B | 9.32B | 9.72B | 9.77B | 9.44B | 9.07B | 8.91B | 8.63B | 8.12B | 8.04B | 7.24B | 6.8B | 5.53B | 4.82B | 4.53B | 4.24B | 3.96B | 3.81B | 3.5B | 3.19B | 3.08B | 3.12B | 3.02B |
| Revenue Growth % | -61.96% | -74.19% | 3.55% | 3.8% | 1.74% | 15.39% | -7.93% | -2.2% | 1.07% | -4.17% | - | 3.52% | 4.06% | 1.83% | 3.25% | 6.21% | 1.07% | 10.97% | 6.51% | 22.89% | 14.75% | 6.57% | 6.62% | 7.18% | 3.8% | 8.89% | 9.95% | 3.38% | -1.11% | 3.24% | 1.43% |
| Cost of Goods Sold | 1.09B | 1.47B | 8.48B | 8.21B | 8.13B | 8.27B | 7.2B | 8.08B | 8.35B | 8.15B | 8.54B | 8.56B | 8.27B | 7.95B | 7.98B | 7.77B | 7.32B | 7.25B | 6.53B | 6.09B | 4.94B | 4.31B | 4.06B | 3.8B | 3.54B | 3.41B | 3.13B | 2.85B | 2.76B | 2.8B | 2.72B |
| COGS % of Revenue | - | 53.32% | 79.26% | 79.44% | 81.65% | 84.54% | 84.9% | 87.75% | 88.63% | 87.42% | 87.79% | 87.57% | 87.61% | 87.69% | 89.62% | 90.06% | 90.06% | 90.21% | 90.1% | 89.49% | 89.22% | 89.3% | 89.76% | 89.49% | 89.4% | 89.3% | 89.28% | 89.49% | 89.39% | 89.84% | 90.12% |
| Gross Profit | 864.69M | 1.29B | 2.22B | 2.13B | 1.83B | 1.51B | 1.28B | 1.13B | 1.07B | 1.17B | 1.19B | 1.21B | 1.17B | 1.12B | 924.65M | 857.54M | 807.73M | 786.91M | 717.26M | 714.98M | 596.8M | 516.11M | 463.3M | 445.99M | 419.87M | 408.24M | 375.67M | 334.8M | 326.9M | 316.8M | 298.4M |
| Gross Margin % | 33.89% | 46.68% | 20.74% | 20.56% | 18.35% | 15.46% | 15.1% | 12.25% | 11.37% | 12.58% | 12.21% | 12.43% | 12.39% | 12.31% | 10.38% | 9.94% | 9.94% | 9.79% | 9.9% | 10.51% | 10.78% | 10.7% | 10.24% | 10.51% | 10.6% | 10.7% | 10.72% | 10.51% | 10.61% | 10.16% | 9.88% |
| Gross Profit Growth % | - | -41.9% | 4.42% | 16.36% | 20.69% | 18.14% | 13.5% | 5.41% | -8.65% | -1.3% | - | 3.81% | 4.73% | 20.81% | 7.83% | 6.17% | 2.64% | 9.71% | 0.32% | 19.8% | 15.63% | 11.4% | 3.88% | 6.22% | 2.85% | 8.67% | 12.21% | 2.42% | 3.19% | 6.17% | 11.43% |
| Operating Expenses | 1.07B | 1.07B | 2.43B | 2.02B | 1.68B | 1.14B | 1.08B | 1.06B | 1.42B | 1.08B | 987.71M | 985.81M | 967.63M | 906.55M | 717.74M | 654.02M | 611.79M | 585.64M | 536.53M | 571.77M | 494.03M | 398.68M | 353.17M | 345.49M | 322.94M | 319.28M | 289.72M | 261.6M | 257.8M | 259.2M | 256.3M |
| OpEx % of Revenue | - | 38.65% | 22.68% | 19.55% | 16.91% | 11.7% | 12.7% | 11.46% | 15.11% | 11.62% | 10.16% | 10.09% | 10.25% | 9.99% | 8.06% | 7.58% | 7.53% | 7.29% | 7.41% | 8.41% | 8.93% | 8.27% | 7.8% | 8.14% | 8.16% | 8.37% | 8.27% | 8.21% | 8.36% | 8.32% | 8.49% |
| Selling, General & Admin | 1.02B | 1.07B | 1.91B | 1.81B | 1.55B | 1.08B | 1.04B | 1.02B | 1.26B | 1.02B | 970.42M | 933.6M | 926.98M | 863.66M | 682.6M | 610.66M | 585.53M | 565.62M | 521.4M | 545.27M | 468.79M | 380.51M | 340.99M | 329.77M | 307.01M | 296.81M | 268.2M | 242.2M | 239.5M | 241.5M | 240.2M |
| SG&A % of Revenue | - | 38.65% | 17.85% | 17.55% | 15.62% | 11.01% | 12.3% | 11.12% | 13.4% | 10.91% | 9.98% | 9.55% | 9.82% | 9.52% | 7.66% | 7.08% | 7.21% | 7.04% | 7.2% | 8.02% | 8.47% | 7.89% | 7.54% | 7.77% | 7.75% | 7.78% | 7.66% | 7.6% | 7.77% | 7.75% | 7.96% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 12.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | 0.12% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 1000K | 0 | 517.13M | 207.09M | 128.62M | 55.59M | 34.05M | 30.67M | 161.12M | 65.64M | 17.29M | 52.21M | 40.65M | 42.89M | 35.14M | 43.37M | 26.25M | 20.02M | 15.13M | 26.5M | 25.24M | 18.17M | 12.19M | 15.72M | 15.93M | 22.47M | 21.52M | 19.4M | 18.3M | 17.7M | 16.1M |
| Operating Income | 40.74M | 221.74M | -207.77M | 104.51M | 142.91M | 368.47M | 204.12M | 73.15M | -352.35M | 89.25M | 199.6M | 200.36M | 159.54M | 198.08M | 196.75M | 203.51M | 195.94M | 201.28M | 180.72M | 143.21M | 102.76M | 117.43M | 110.13M | 100.5M | 97.42M | 90.44M | 85.95M | 73.2M | 69.1M | 57.6M | 42.1M |
| Operating Margin % | 1.6% | 8.03% | -1.94% | 1.01% | 1.44% | 3.77% | 2.41% | 0.79% | -3.74% | 0.96% | 2.05% | 2.05% | 1.69% | 2.18% | 2.21% | 2.36% | 2.41% | 2.5% | 2.5% | 2.11% | 1.86% | 2.44% | 2.43% | 2.37% | 2.46% | 2.37% | 2.45% | 2.3% | 2.24% | 1.85% | 1.39% |
| Operating Income Growth % | - | 206.72% | -298.81% | -26.87% | -61.21% | 80.52% | 179.04% | 120.76% | -494.78% | -55.28% | - | 25.59% | -19.46% | 0.68% | -3.32% | 3.87% | -2.65% | 11.37% | 26.19% | 39.36% | -12.49% | 6.63% | 9.58% | 3.17% | 7.72% | 5.22% | 17.42% | 5.93% | 19.97% | 36.82% | 58.87% |
| EBITDA | 198.06M | 436.26M | 57.01M | 391.88M | 371.58M | 459.09M | 297.45M | 189.83M | -268.95M | 148.69M | 254.99M | 266.34M | 222.94M | 248.67M | 236.36M | 237.65M | 225.08M | 226.54M | 202.68M | 182.35M | 131.7M | 136.68M | 125.01M | 116.22M | 113.34M | 112.91M | 107.47M | 92.6M | 87.4M | 75.3M | 58.2M |
| EBITDA Margin % | 7.76% | 15.79% | 0.53% | 3.79% | 3.73% | 4.69% | 3.51% | 2.06% | -2.86% | 1.6% | 2.62% | 2.73% | 2.36% | 2.74% | 2.65% | 2.75% | 2.77% | 2.82% | 2.8% | 2.68% | 2.38% | 2.83% | 2.76% | 2.74% | 2.86% | 2.96% | 3.07% | 2.91% | 2.84% | 2.42% | 1.93% |
| EBITDA Growth % | 133.86% | 665.29% | -85.45% | 5.46% | -19.06% | 54.34% | 56.7% | 170.58% | -280.87% | -41.69% | - | 19.47% | -10.35% | 5.21% | -0.54% | 5.58% | -0.64% | 11.77% | 11.15% | 38.46% | -3.65% | 9.34% | 7.57% | 2.54% | 0.39% | 5.06% | 16.06% | 5.95% | 16.07% | 29.38% | 38.9% |
| D&A (Non-Cash Add-back) | 157.31M | 214.52M | 264.77M | 287.38M | 228.67M | 90.62M | 93.34M | 116.68M | 83.4M | 59.44M | 55.39M | 65.98M | 63.41M | 50.59M | 39.6M | 34.13M | 29.15M | 25.27M | 21.95M | 39.14M | 28.93M | 19.25M | 14.88M | 15.72M | 15.93M | 22.47M | 21.52M | 19.4M | 18.3M | 17.7M | 16.1M |
| EBIT | -17.03M | 5.23M | -213.55M | 103.19M | 139.78M | 324.84M | 240.28M | 99.28M | -356.11M | 149.96M | 224.27M | 200.36M | 144.65M | 210.53M | 196.75M | 203.51M | 195.94M | 201.28M | 180.72M | 143.21M | 102.76M | 117.43M | 110.13M | 105.71M | 101.58M | 88.96M | 85.95M | 73.22M | 69.15M | 57.6M | 42.1M |
| Net Interest Income | -94.82M | -107.18M | -143.8M | -157.91M | -128.89M | -48.09M | -83.4M | -98.11M | -70.98M | -31.77M | -27.06M | -27.15M | -18.16M | -13.1M | -13.4M | -13.68M | -14.32M | -13.03M | -16M | -22.98M | -13.27M | -11.86M | -12.26M | -8.96M | -10.4M | -13.36M | -12.57M | 0 | -14.1M | 0 | -19M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 132.44M | 107.18M | 143.8M | 157.91M | 128.89M | 48.09M | 83.4M | 98.11M | 70.98M | 31.77M | 27.06M | 27.15M | 18.16M | 13.1M | 13.4M | 13.68M | 14.32M | 13.03M | 16M | 22.98M | 13.27M | 11.86M | 12.26M | 8.96M | 10.4M | 13.36M | 12.57M | 0 | 14.1M | 0 | 19M |
| Other Income/Expense | -189.41M | -323.69M | -149.59M | -159.23M | -132.02M | -91.72M | -94.21M | -101.87M | -74.75M | -31.77M | -27.06M | -27.15M | -33.05M | -13.1M | -19.1M | -13.68M | -14.32M | -13.03M | -16M | -22.98M | -24.68M | -11.86M | -12.52M | -17.91M | -23.3M | -37.64M | -25.79M | -23.16M | -34.41M | -15.7M | -19M |
| Pretax Income | -148.66M | -101.95M | -357.36M | -54.73M | 10.89M | 276.75M | 109.91M | -28.72M | -427.09M | 57.48M | 172.54M | 173.21M | 126.48M | 184.99M | 183.36M | 189.83M | 181.61M | 188.25M | 164.73M | 120.23M | 78.08M | 105.57M | 97.61M | 87.8M | 78.2M | 64.58M | 60.16M | 50.1M | 34.7M | 41.9M | 23.1M |
| Pretax Margin % | -5.83% | -3.69% | -3.34% | -0.53% | 0.11% | 2.83% | 1.3% | -0.31% | -4.53% | 0.62% | 1.77% | 1.77% | 1.34% | 2.04% | 2.06% | 2.2% | 2.24% | 2.34% | 2.27% | 1.77% | 1.41% | 2.19% | 2.16% | 2.07% | 1.97% | 1.69% | 1.72% | 1.57% | 1.13% | 1.34% | 0.77% |
| Income Tax | -25.72M | 729K | 5.33M | -13.43M | -11.5M | 55.16M | 21.83M | -6.13M | 32.43M | -15.31M | 63.76M | 69.8M | 59.98M | 74.1M | 74.35M | 74.64M | 71.03M | 71.39M | 63.47M | 47.52M | 29.33M | 41.15M | 37.11M | 34.16M | 30.98M | 34.47M | 27.07M | 22.1M | 14.6M | 17.6M | 10.1M |
| Effective Tax Rate % | 17.3% | -0.72% | -1.49% | 24.53% | -105.57% | 19.93% | 19.87% | 21.36% | -7.59% | -26.64% | 36.95% | 40.3% | 47.42% | 40.06% | 40.55% | 39.32% | 39.11% | 37.92% | 38.53% | 39.52% | 37.56% | 38.98% | 38.02% | 38.9% | 39.62% | 53.38% | 45% | 44.11% | 42.07% | 42% | 43.72% |
| Net Income | -171.56M | -1.1B | -362.69M | -41.3M | 22.39M | 221.59M | 29.87M | -62.37M | -437.01M | 72.79M | 108.79M | 103.41M | 66.5M | 110.88M | 109M | 115.2M | 110.58M | 104.66M | 93.33M | 72.71M | 48.75M | 64.42M | 60.5M | 53.64M | 47.27M | 23.04M | 33.09M | 28M | 20.1M | 24.3M | 13M |
| Net Margin % | -6.72% | -39.85% | -3.39% | -0.4% | 0.22% | 2.26% | 0.35% | -0.68% | -4.64% | 0.78% | 1.12% | 1.06% | 0.7% | 1.22% | 1.22% | 1.34% | 1.36% | 1.3% | 1.29% | 1.07% | 0.88% | 1.34% | 1.34% | 1.26% | 1.19% | 0.6% | 0.94% | 0.88% | 0.65% | 0.78% | 0.43% |
| Net Income Growth % | 87.2% | -203.47% | -778.15% | -284.47% | -89.9% | 641.82% | 147.89% | 85.73% | -700.35% | -33.09% | - | 55.5% | -40.02% | 1.72% | -5.38% | 4.18% | 5.66% | 12.14% | 28.36% | 49.14% | -24.32% | 6.48% | 12.79% | 13.49% | 105.2% | -30.38% | 18.17% | 39.3% | -17.28% | 86.92% | 215.04% |
| Net Income (Continuing) | -104.98M | -102.68M | -362.69M | -41.3M | 22.39M | 221.59M | 88.07M | -22.58M | -394.67M | 72.79M | 108.79M | 103.41M | 66.5M | 110.88M | 109M | 115.2M | 110.58M | 116.86M | 101.26M | 72.71M | 48.75M | 64.42M | 60.5M | 53.64M | 47.27M | 23.04M | 33.09M | 27.98M | 20.14M | 24.3M | 13M |
| Discontinued Operations | -1000K | -997.96M | 0 | 0 | 0 | 0 | -58.2M | -39.79M | -42.35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.13M | 1.13M | 1.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 132M | 132M | 132M | 132M | 0 | 0 |
| EPS (Diluted) | - | -14.31 | -4.73 | -0.54 | 0.29 | 2.94 | 0.47 | -0.37 | -7.28 | 1.20 | 1.76 | 1.65 | 1.06 | 1.76 | 1.72 | 1.81 | 1.75 | 1.67 | 1.50 | 1.19 | 0.80 | 1.07 | 1.02 | 0.95 | 0.85 | 0.45 | 0.63 | 0.55 | 0.37 | 0.40 | 0.17 |
| EPS Growth % | 88.65% | -202.54% | -775.93% | -286.21% | -90.14% | 525.53% | 227.03% | 94.92% | -706.67% | -31.82% | - | 55.66% | -39.77% | 2.33% | -4.97% | 3.43% | 4.79% | 11.33% | 26.05% | 48.75% | -25.23% | 4.9% | 7.37% | 11.76% | 88.89% | -28.57% | 14.55% | 48.65% | -7.5% | 135.29% | 170.83% |
| EPS (Basic) | - | -14.31 | -4.73 | -0.54 | 0.30 | 3.05 | 0.47 | -0.37 | -7.28 | 1.20 | 1.76 | 1.65 | 1.06 | 1.76 | 1.72 | 1.82 | 1.76 | 1.68 | 1.53 | 1.21 | 0.81 | 1.09 | 1.03 | 1.01 | 0.93 | 0.46 | 0.67 | 0.57 | 0.37 | 0.40 | 0.17 |
| Diluted Shares Outstanding | 0 | 76.9M | 76.74M | 75.78M | 76.22M | 75.49M | 63.51M | 60.57M | 60.01M | 60M | 61.09M | 62.12M | 62.23M | 62.66M | 62.84M | 62.92M | 62.56M | 62.08M | 62.24M | 60.93M | 60.94M | 60.02M | 59.31M | 56.66M | 55.83M | 50.81M | 52.8M | 51.18M | 48.88M | 47.75M | 47.66M |
| Basic Shares Outstanding | 0 | 76.9M | 76.74M | 75.78M | 74.5M | 72.74M | 63.37M | 60.57M | 60.01M | 60M | 61.09M | 62.12M | 62.22M | 62.63M | 62.77M | 62.76M | 62.31M | 61.72M | 61.19M | 60.26M | 59.94M | 59.28M | 58.55M | 52.94M | 50.64M | 50.08M | 49.14M | 48.8M | 48.88M | 47.75M | 47.66M |
| Dividend Payout Ratio | - | - | - | - | - | 0.33% | 2.17% | - | - | 86.75% | 58.26% | 61.55% | 94.89% | 54.77% | 51.08% | 44.19% | 40.5% | 36.66% | 35.41% | 38.01% | 49.42% | 32.15% | 28.63% | 23.73% | 22.36% | 39.86% | 24.65% | 26.79% | 46.27% | 45.27% | 83.85% |
Quick answers to the most common questions about buying ACH stock.
For fiscal year 2025, Accendra Health, Inc. (ACH) reported total revenue of $2.76B. This represents a 8.5% decline compared to $3.02B in 1996.
Accendra Health, Inc. (ACH) reported a net loss of $1.10B for the fiscal year ending 2025.
Accendra Health, Inc. (ACH) reported an operating income of $221.7M, resulting in an operating profit margin of 8.0%. This margin reflects the operational efficiency of the business before interest and taxes.
Accendra Health, Inc. (ACH) generated $1.29B in gross profit for the year, representing a gross profit margin of 46.7%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Structural revenue and margin volatility
Metrics are mathematically derived from official filings.
Revenue Volatility Masks Underlying Trends
As reported in recent financial filings, OMI's revenue trajectory exhibits extreme instability, highlighted by a 146.3% contraction in 2025Q4, which suggests that the company is undergoing a fundamental shift in its reporting scope or experiencing significant divestiture activity that obscures its core organic growth performance.
The erratic revenue figures, oscillating between multi-billion dollar quarters and sub-billion dollar periods, suggest that the company's business model is currently in a state of flux. Investors should monitor whether these fluctuations represent a permanent downsizing of the distribution footprint or merely a transition in revenue recognition practices.
Gross Margin Expansion Lacks Sustainability
Based on the provided income statement data, OMI's gross margin reached an anomalous 93.9% in 2025Q4, a figure that appears disconnected from the company's historical 20-48% range and warrants deep investigation into potential accounting adjustments or non-recurring items that artificially inflated the reported profitability metrics.
The extreme variance in gross margins suggests that the underlying cost of goods sold is being impacted by significant, non-operational accounting events. Such volatility makes it difficult to assess the true pricing power of the Global Products segment or the efficiency of the distribution business.
Net Losses Undermine Earnings Quality
According to the quarterly income statements, OMI has consistently reported net losses, including a staggering $869.1 million deficit in 2025Q2, which indicates that the company's core operations are currently unable to cover interest burdens and other non-operating expenses, raising concerns regarding long-term earnings viability.
The persistent gap between operating income and net income suggests that the company is burdened by significant non-operating costs, likely related to debt service or impairment charges. This disconnect implies that reported EPS figures may not reflect the true cash-generating capacity of the business.
Structural Risks to Operational Viability
As indicated by the reported data, OMI's operating margin has frequently dipped into negative territory, such as the -9.7% margin observed in 2024Q4, which suggests that the company's high-variable-cost distribution model may be struggling to maintain profitability amidst competitive pricing pressures and rising operational overhead.
Short-sellers would likely focus on the inability of the company to maintain consistent positive operating margins, which is a prerequisite for a low-margin distribution business. The reliance on non-core items to bridge the gap to profitability warrants further investigation into the sustainability of the current cost structure.